- Investing Ideas
- /
- Retail Healthcare Sector
Retail Healthcare Sector
Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
Biodexa Pharmaceuticals
Market Cap: US$3.3m
A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain.
BDRX
US$1.28
7D
-9.2%
1Y
-95.7%
4Front Ventures
Market Cap: CA$4.6m
Owns and manages licensed cannabis facilities in state-licensed markets in the United States.
FFNT
CA$0.005
7D
0%
1Y
-97.1%
Lobe Sciences
Market Cap: CA$4.6m
A biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada.
LOBE
CA$0.025
7D
0%
1Y
25.0%
RedHill Biopharma
Market Cap: US$3.2m
A specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases.
RDHL
US$1.85
7D
-7.5%
1Y
-84.4%
Herbal Dispatch
Market Cap: CA$4.5m
Owns and operates cannabis e-commerce platforms in Canada and the United States.
HERB
CA$0.055
7D
-8.3%
1Y
10.0%
Enveric Biosciences
Market Cap: US$3.2m
A biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders.
ENVB
US$1.30
7D
1.6%
1Y
-89.7%
Endexx
Market Cap: US$3.2m
Engages in the manufacturing and sale of cannabidiol (CBD)-based products for the health and wellness market.
EDXC
US$0.0054
7D
-6.9%
1Y
-75.6%
Eyenovia
Market Cap: US$3.2m
An ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States.
EYEN
US$1.13
7D
4.6%
1Y
-98.1%
Traack Technologies
Market Cap: US$3.2m
Provides business and finance advisory services for small and medium sized companies.
TRAA
US$0.18
7D
0%
1Y
88.1%
iCoreConnect
Market Cap: US$3.2m
A cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States.
ICCT
US$2.29
7D
28.7%
1Y
-89.8%
CERo Therapeutics Holdings
Market Cap: US$3.1m
An immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer.
CERO
US$0.58
7D
-10.0%
1Y
-99.5%
Willow Biosciences
Market Cap: CA$4.3m
Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.
WLLW
CA$0.03
7D
-14.3%
1Y
-66.7%
Ethema Health
Market Cap: US$3.1m
Operates behavioral healthcare space specifically in the treatment of substance use disorders.
GRST
US$0.0004
7D
33.3%
1Y
0%
Actavia Life Sciences
Market Cap: US$3.1m
A leukemia-focused biotechnology company, engages in developing therapeutics for the treatment of acute myeloid leukemia (AML) and other forms of leukemia and lymphoma.
RASP
US$0.004
7D
0%
1Y
-48.1%
Roquefort Therapeutics
Market Cap: UK£2.3m
A material biotech company, engages in the development of medicines for the treatment of cancer.
ROQ
UK£0.015
7D
-9.1%
1Y
-65.5%
Zelira Therapeutics
Market Cap: AU$4.8m
A biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of a variety of medical conditions in Australia and the United States.
ZLD
AU$0.40
7D
-7.0%
1Y
-18.4%
Oxford Cannabinoid Technologies Holdings
Market Cap: US$3.0m
A pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines.
OCTH.F
US$0.0028
7D
0%
1Y
n/a
Psyence Biomedical
Market Cap: US$3.0m
Engages in the development of botanical psilocybin-based psychedelic medicines.
PBM
US$5.20
7D
37.9%
1Y
-99.0%
AquaBounty Technologies
Market Cap: US$3.0m
Operates as a land-based aquaculture company in the United States.
AQB
US$0.78
7D
18.4%
1Y
-57.1%
Palisade Bio
Market Cap: US$3.0m
A clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases.
PALI
US$0.69
7D
-9.0%
1Y
-89.2%
Artelo Biosciences
Market Cap: US$3.0m
A clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.
ARTL
US$0.92
7D
-9.8%
1Y
-35.2%
ASEP Medical Holdings
Market Cap: CA$4.2m
Focuses on developing diagnostic and therapeutic solutions for the treatment of sepsis.
ASEP
CA$0.50
7D
0%
1Y
-75.0%
Longevity Health Holdings
Market Cap: US$3.0m
A bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products.
XAGE
US$3.00
7D
-34.6%
1Y
-95.1%
Synaptogenix
Market Cap: US$3.0m
Operates as a biopharmaceutical company.
SNPX
US$2.16
7D
-10.4%
1Y
-54.5%
Global Health
Market Cap: AU$4.6m
Provides digital health solutions for the healthcare industry in Australia.
GLH
AU$0.079
7D
-14.1%
1Y
-21.0%
Windtree Therapeutics
Market Cap: US$2.9m
A biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases.
WINT
US$0.83
7D
-2.8%
1Y
-99.6%
Aoxing Pharmaceutical Company
Market Cap: US$2.9m
A specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China.
AOXG
US$0.0076
7D
15.2%
1Y
5.6%
VirExit Technologies
Market Cap: US$2.9m
Develops and provides antiviral technologies, personal protective equipment, and health and wellness products.
VXIT
US$0.0008
7D
-11.1%
1Y
-11.1%
Qualigen Therapeutics
Market Cap: US$2.8m
A clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States.
QLGN
US$3.87
7D
7.8%
1Y
-73.6%
BioTech Medics
Market Cap: US$2.8m
Operates as a medical-based holding company.
BMCS
US$0.014
7D
0%
1Y
-26.3%
ReShape Lifesciences
Market Cap: US$2.8m
Provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally.
RSLS
US$6.28
7D
-5.7%
1Y
-97.5%
iSpecimen
Market Cap: US$2.8m
Operates marketplace that provides biospecimens to life science researchers worldwide.
ISPC
US$1.13
7D
-0.7%
1Y
-76.6%
9 Meters Biopharma
Market Cap: US$2.8m
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America.
NMTR
US$0.20
7D
-71.1%
1Y
-96.0%
Tharimmune
Market Cap: US$2.8m
A clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic conditions with high unmet need in the United States.
THAR
US$1.33
7D
-11.9%
1Y
-75.4%
TILT Holdings
Market Cap: CA$3.9m
Provides various cannabis products and services in the United States, Canada, and internationally.
TILT
CA$0.01
7D
0%
1Y
-75.0%
Bod Science
Market Cap: AU$4.3m
Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States.
BOD
AU$0.024
7D
0%
1Y
-65.2%